Amgen Inc (AMGN) 130.01 $AMGN
Asian markets drift after US Fed stays course
By KAY JOHNSON - AP - Wed Jul 30, 11:37PM CDT
MUMBAI, India (AP) — Asian stock markets were uninspired by an upbeat report on the U.S. economy, with most drifting lower Thursday after the U.S. Federal Reserve said it would make further cuts to its monetary stimulus as expected.
Final Glance: Biotechnology companies
AP - Wed Jul 30, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Amgen Set to Possibly Pullback After Yesterday's Rally of 5.43%
Comtex SmarTrend(R) - Wed Jul 30, 3:39PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $128.63 to a high of $131.24. Yesterday, the shares gained 5.4%, which took the trading range above the 3-day high of $124.39 on volume of 8.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion
at The Street - Wed Jul 30, 3:31PM CDT
Major U.S. stock markets are mixed on Wednesday as the Federal Reserve maintains its federal funds rate and cuts monthly bond buying by $10 billion to $25 billion.
Today's Trades: 3 Big Stocks Getting Big Attention
at The Street - Wed Jul 30, 1:18PM CDT
Here's how to trade some of the most active stocks on the market today.
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement
at The Street - Wed Jul 30, 12:50PM CDT
U.S. stocks slip on Wednesday as positive sentiment gives way to nerves ahead of the Federal Reserve's policy announcement.
Midday Glance: Biotechnology companies
AP - Wed Jul 30, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Amgen Restructuring Plan, Q2 Earnings Send Stock Up
at Investor's Business Daily - Wed Jul 30, 10:20AM CDT
Amgen (AMGN) was up more than 5%, near 129, in early trading in the stock market today as analysts approved of big-cap biotech's earnings beat and restructuring plans announced late Tuesday. Earlier, Amgen stock touched a new high above 131. Amgen's...
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
at The Street - Wed Jul 30, 10:05AM CDT
Amgen's reallocation of resources is not quieting critics who want a bigger restructuring.
Early Glance: Biotechnology companies
AP - Wed Jul 30, 9:42AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stock Market News for July 30, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 9:10AM CDT
Benchmarks settled in the red zone on Tuesday after a choppy session as the U.S. and the European Union expanded economic sanctions against Russia
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain
Marketwire - Wed Jul 30, 9:00AM CDT
Resilinc Corp., the leading provider of supply chain resiliency solutions, today announced that it has been named a 2014 Great Supply Chain Partner by SupplyChainBrain. Resilinc was nominated by Amgen for its contributions to Amgen's global supply chain resiliency strategy as detailed in a recently published interactive case study. Resilinc will appear in the 2014 July/August issue of SupplyChainBrain magazine.
Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 30, 8:20AM CDT
While Amgen's (AMGN) second quarter results were impressive, the company's restructuring plan remained in focus.
Will This Price Target Increase Help Amgen (AMGN) Stock Today?
at The Street - Wed Jul 30, 8:02AM CDT
Credit Suisse increased its price target on Amgen (AMGN) to $135, increased its estimates and set a "neutral" rating based on the company's new guidance.
Stock Market Today: Futures Rise Ahead of GDP, Fed; Twitter Shares Soar
at The Street - Wed Jul 30, 7:14AM CDT
U.S. stock futures are pointing to a rebound on Wall Street Wednesday as investors anticipate stronger second-quarter GDP.
July 30 Premarket Briefing: 10 Things You Should Know
at The Street - Wed Jul 30, 6:29AM CDT
U.S. stock futures were bounding upward on Wednesday morning, as bulls rejoiced in Twitter's report and investors set up for another big earnings day.
Biotech drugmaker Amgen laying off at least 2,400
By LINDA A. JOHNSON - AP - Tue Jul 29, 6:17PM CDT
Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.
Why Amgen (AMGN) Stock Is Up in After-Hours Trading Today
at The Street - Tue Jul 29, 3:42PM CDT
Amgen (AMGN) rose in after-hours trading on Tuesday after the biopharmaceutical company reported second-quarter earnings that beat analysts' expectations.
Asian markets drift after US Fed stays course
By KAY JOHNSON - AP - Wed Jul 30, 11:37PM CDT
MUMBAI, India (AP) — Asian stock markets were uninspired by an upbeat report on the U.S. economy, with most drifting lower Thursday after the U.S. Federal Reserve said it would make further cuts to its monetary stimulus as expected.
Final Glance: Biotechnology companies
AP - Wed Jul 30, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Amgen Set to Possibly Pullback After Yesterday's Rally of 5.43%
Comtex SmarTrend(R) - Wed Jul 30, 3:39PM CDT
Amgen (NASDAQ:AMGN) traded in a range yesterday that spanned from a low of $128.63 to a high of $131.24. Yesterday, the shares gained 5.4%, which took the trading range above the 3-day high of $124.39 on volume of 8.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion
at The Street - Wed Jul 30, 3:31PM CDT
Major U.S. stock markets are mixed on Wednesday as the Federal Reserve maintains its federal funds rate and cuts monthly bond buying by $10 billion to $25 billion.
Today's Trades: 3 Big Stocks Getting Big Attention
at The Street - Wed Jul 30, 1:18PM CDT
Here's how to trade some of the most active stocks on the market today.
Stock Market Today: Stocks Slip Ahead of Fed Policy Announcement
at The Street - Wed Jul 30, 12:50PM CDT
U.S. stocks slip on Wednesday as positive sentiment gives way to nerves ahead of the Federal Reserve's policy announcement.
Midday Glance: Biotechnology companies
AP - Wed Jul 30, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Amgen Restructuring Plan, Q2 Earnings Send Stock Up
at Investor's Business Daily - Wed Jul 30, 10:20AM CDT
Amgen (AMGN) was up more than 5%, near 129, in early trading in the stock market today as analysts approved of big-cap biotech's earnings beat and restructuring plans announced late Tuesday. Earlier, Amgen stock touched a new high above 131. Amgen's...
Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
at The Street - Wed Jul 30, 10:05AM CDT
Amgen's reallocation of resources is not quieting critics who want a bigger restructuring.
Early Glance: Biotechnology companies
AP - Wed Jul 30, 9:42AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stock Market News for July 30, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 9:10AM CDT
Benchmarks settled in the red zone on Tuesday after a choppy session as the U.S. and the European Union expanded economic sanctions against Russia
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain
Marketwire - Wed Jul 30, 9:00AM CDT
Resilinc Corp., the leading provider of supply chain resiliency solutions, today announced that it has been named a 2014 Great Supply Chain Partner by SupplyChainBrain. Resilinc was nominated by Amgen for its contributions to Amgen's global supply chain resiliency strategy as detailed in a recently published interactive case study. Resilinc will appear in the 2014 July/August issue of SupplyChainBrain magazine.
Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jul 30, 8:20AM CDT
While Amgen's (AMGN) second quarter results were impressive, the company's restructuring plan remained in focus.
Will This Price Target Increase Help Amgen (AMGN) Stock Today?
at The Street - Wed Jul 30, 8:02AM CDT
Credit Suisse increased its price target on Amgen (AMGN) to $135, increased its estimates and set a "neutral" rating based on the company's new guidance.
Stock Market Today: Futures Rise Ahead of GDP, Fed; Twitter Shares Soar
at The Street - Wed Jul 30, 7:14AM CDT
U.S. stock futures are pointing to a rebound on Wall Street Wednesday as investors anticipate stronger second-quarter GDP.
July 30 Premarket Briefing: 10 Things You Should Know
at The Street - Wed Jul 30, 6:29AM CDT
U.S. stock futures were bounding upward on Wednesday morning, as bulls rejoiced in Twitter's report and investors set up for another big earnings day.
Biotech drugmaker Amgen laying off at least 2,400
By LINDA A. JOHNSON - AP - Tue Jul 29, 6:17PM CDT
Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.
Why Amgen (AMGN) Stock Is Up in After-Hours Trading Today
at The Street - Tue Jul 29, 3:42PM CDT
Amgen (AMGN) rose in after-hours trading on Tuesday after the biopharmaceutical company reported second-quarter earnings that beat analysts' expectations.
